1. Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ. Manson’s tropical diseases e-book: Elsevier Health Sciences; 2013.
2. Johnson PD, Stinear T, Pamela L, Pluschke G, Merritt RW, Portaels F, et al. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med. 2005;2(4):e108.
3. Organization WH, Initiative GBU. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). 2004.
4. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, et al. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science. 1999;283(5403):854–7.
5. • Organization WH. Treatment of Mycobacterium ulcerans disease (Buruli ulcer): guidance for health workers. 2012. This is the first WHO guideline which first advocates the use of antimicrobial treatment in BU.